Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Ryan Abbott, MD, JD, PhD
Advertisement
Dr Abbott is a professor of Law and Health Sciences at the University of Surrey School of Law and adjunct assistant professor of Medicine at the David Geffen School of Medicine at UCLA.
Articles by Ryan Abbott, MD, JD, PhD
Brain Capital: An Emerging Investment Opportunity
ByHarris A. Eyre, MD, PhD,Mark Faulkenberg,Sanjiv Das,James T. Hackett,Shuo Chen, JD,Francois Véron,Pawel Swieboda,Geoffrey S.F. Ling, MD, PhD,Eric W. Bennett,Shekhar Saxena, MD,Steve Carnevale,Ethan Powell,Erin Smith,Agustin Ibañez, PhD,Stephen T. Wong, PhD,Eric A. Storch, PhD,Evelyn Chan, MBBS, MSc,Mark Heinemeyer,Ian Robertson, PhD,Walter D. Dawson, DPhil,Dapo Tomori, MD,Jair C. Soares, MD,Ryan Abbott, MD, JD, PhD,Sebastian F. Winter, MD,Sandra Bond Chapman, PhD,Anastasia Budinskaya, MSc,Lisa Brown, PhD,Lynne Corner, PhD,Kirk Nylen, PhD,Garth Smith, PhD,Tom Mikkelsen, MD,Michael Berk, MD, PhD
Brain Capital: a fresh approach to technologies and investing.
Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle
ByHenry Asher,Erin Smith,Mark Heinemeyer,Michael Berk, MD, PhD,Agustin Ibañez, PhD,Shuo Chen, JD,Ernestine Fu, PhD,Jessica Wolfe, PhD, MPH,Ryan Abbott, MD, JD, PhD,Francois Véron,William Ellsworth,Marion Leboyer, MD, PhD,Geoffrey S.F. Ling, MD, PhD,Igor Linkov, PhD, MSc,Magali Haas, MD, PhD,Harris A. Eyre, MD, PhD
New approaches to ensure that the brain health technology sector continues to flourish for decades.
Information asymmetry occurs when one party has more or better information than the other party. Asymmetry and fraud will sour investor interest in the field.
Boosting Brain Health After COVID-19: A Convergence Solution
ByHarris A. Eyre, MD, PhD,Jessica Carson,Erin Smith,Helen Lavretsky, MD, MS,Charles F. Reynolds III, MD,Husseini K. Manji, MD,Walter D. Dawson, DPhil,Laura Booi, PhD,Mark Heinemeyer,Jeffrey L. Cummings, MD, ScD,Ernestine Fu, PhD,Eric A. Storch, PhD,William Hynes, DPhil,Eric J. Lenze, MD,Retsina Meyer, PhD,Ian Macrae, PhD,Antonella Santuccione Chadha, MD,Ryan Abbott, MD, JD, PhD,Sandra Bond Chapman, PhD,Ian Robertson, PhD,Carol Graham,Brisa S. Fernandes, MD, MSc, PhD,David G. Angeler, PhD,Adrienne Grzenda, MD, PhD,Agustin Ibañez, PhD,Zoltan Sarnyai, MD, PhD,Sofia Marcha,Michael Berk, MD, PhD,Patrick Brannelly
How can we face the current pandemic while addressing the brain health crisis?
Advertisement
Latest Updated Articles
Boosting Brain Health After COVID-19: A Convergence SolutionPublished: May 14th 2021 | Updated:
Telling Humanity’s Brain Story: Insights From Brain CapitalPublished: January 19th 2023 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD
2
Whatever Happened to Psychopathology?
3
Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
4
How Can Chatbots Be Made Safe for Psychiatric Patients
5
